Open Access DOI:10.23937/2572-4045.1510057
Organ Transplantation in Turkey: Experience of Organ Transportation by Airway
Eren USUL, MD, Anıl Gökçe, Afşin Emre KAYIPMAZ and Semih KORKUT
Article Type: Original Article | First Published: November 22, 2020
Transplantation is a multidisciplinary treatment that covers all procedures that allow live cells or tissues to be transferred from donor to recipient and live in recipient to function. Transplantation network is not only innovative technological techniques that reduce damage to organs due to ischemia time, a complex system of activities that standardization process must take into account more variables. In our study, in organ transplants performed between January 2017 and December 2019, the tra...
Open Access DOI:10.23937/2572-4045.1510056
Therapeutic Plasma Exchange in Small-Bowel Transplant Recipients
Aleh Bobr, MD, Whitney L Reid, DO, Sara M Shunkwiler, MD, Jesse L Cox, MD, PhD and Scott A Koepsell, MD, PhD
Article Type: Original Article | First Published: October 26, 2020
Therapeutic plasma exchange (TPE) is an important adjunct therapy to reduce levels of donor-specific antibodies (DSAs) associated with antibody mediated rejection (AMR) in solid organ transplant recipients, especially kidney recipients. The purpose of this study was to examine the effect of TPE on DSAs and clinical/pathologic evidence of rejection in small bowel transplant recipients. ...
Open Access DOI:10.23937/2572-4045.1510055
The Impact of Different Induction Immunosuppressive Therapy on Long Term Kidney Transplant Function When Measured by Iothalamate Clearance
Tambi Jarmi, MD, Samir Khouzam, MD, Nitika Shekhar, Launia White, BS, David O Hodge, Martin L Mai, MD and Hani M Wadei, MD
Article Type: Original Article | First Published: October 17, 2020
Improvement in short term outcomes after kidney transplant has been achieved by using different induction and maintenance therapeutic approaches. Long term outcomes have not matched the expectations of the transplant stakeholders. Our study aimed to address the early impact of induction agents on long term outcome of kidney transplant when measured by Iothalamate clearance. All adult kidney transplant recipients between January of 2012 and December of 2016 were reviewed. 649 patients were divide...
Open Access DOI:10.23937/2572-4045.1510054
Early Cardiovascular Events and Cardiovascular Death after Renal Transplantation: Role of Pretransplant Risk Factors
Jose Jayme G De Lima, MD, PhD, Luis Henrique W Gowdak, MD, PhD, Flavio J de Paula, MD, PhD, Elias David-Neto MD, PhD and Luiz A Bortolotto MD, PhD
Article Type: Original Research | First Published: October 03, 2020
The purpose of this study was to verify the risk factors present in patients on the kidney transplant waiting list that may interfere with the incidence of CV events and death during the first 12 months after transplantation. Based on data collected prospectively during pre-transplant workup, a retrospective study was conducted including 665 patients followed up until death or completing 12 months post-transplantation. Endpoints were the composite incidence of CV events and death. The prevalence...
